REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
53,769,139
Share change
+420,776
Total reported value
$9,050,236,781
Put/Call ratio
55%
Price per share
$168.36
Number of holders
442
Value change
+$70,900,818
Number of buys
202
Number of sells
200

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2023

As of 31 Mar 2023 REPLIGEN CORP - COMMON STOCK (RGEN) had 442 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 53,769,139 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, Invesco Ltd., and Artisan Partners Limited Partnership.
This table shows 442 institutional shareholders of the security as of 31 Mar 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.